Abstract:Introduction T2* weighted gradient echo MRI has been increasingly recognized as a sensitive tool in detecting intracerebral hemorrhage. However, its blooming artifacts is highly dependent on imaging parameters including TE, field strength and voxel size, making it difficult to reliably estimate the hematoma volume, a key predictor of morbidity and mortality of hemorrhage. Recently, a novel quantitative susceptibility mapping (QSM) technology has been developed for processing gradient echo MRI data to map tissue susceptibility property without blooming artifacts and dependence on imaging parameters. Hypothesis We assessed the hypothesis that hematoma volume measurement on QSM is independent of imaging parameters, eliminating its TE dependence on gradient echo MRI. Method A retrospective image analysis of MRI was approved by our IRB with HIPPA compliance. We randomly selected 16 patients who underwent intracerebral hemorrhage MRI including a 3D multiecho T2*w sequence: 8-11 echoes with first echo TE/ echo spacing/ TR= 5/5/50 msec. Postprocessed images of gradient echo MRI included susceptibility weighted imaging (SWI), R2* (quantitative 1/T2* mapping), and QSM at various TEs. Hematoma volumes were measured from all these images. Results Linear regression of hematoma volume vs TE over all subjects showed substantial slopes for gradient echo magnitude (0.45±0.31 L/s), SWI (0.52±0.46) and R2* (0.39±0.30) but nearly zero slope for QSM (0.01±0.05). At TE=20 msec, hematoma volume on QSM was 0.80x that on gradient echo magnitude image (R2=0.99), and hematoma volume on CT is also 0.8x that on gradient echo magnitude image according to literature (Stroke 2008;39:2017-2020). Conclusion In conclusion, quantitative susceptibility mapping can provide reliable measurement of hematoma volume, independent echo time and similar to CT.

Macroscopic Susceptibility in Ultra High Field MRI

Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Abstract WP292: Quantitative Susceptibility Mapping for Reliably Measuring Hematoma Volume in Magnetic Resonance Imaging

Dielectric Resonance Phenomena in Ultra High Field MRI

Pros and cons of ultra-high-field MRI/MRS for human application

Challenges and Opportunities of Ultra-High Field MRI

Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping.

Ultra‐low‐field magnetization transfer imaging at 0.055T with low specific absorption rate

Magnetic Susceptibility Anisotropy of Human Brain in Vivo and Its Molecular Underpinnings

Susceptibility effects in nuclear magnetic resonance imaging

Susceptibility-weighted imaging at high-performance 0.5T magnetic resonance imaging system: Protocol considerations and experimental results

Ultrashort echo time and zero echo time MR imaging and their applications at high magnetic fields: A literature survey

Adaptive Suppression of Power Line Interference in Ultra-Low Field Magnetic Resonance Imaging in an Unshielded Environment.

Safety considerations in MR imaging.

Quantitative Susceptibility Mapping of Human Brain Reflects Spatial Variation in Tissue Composition

Signal Improvement and Contrast Enhancement in Magnetic Resonance Imaging

Detailing magnetic field strength dependence and segmental artifact distribution of myocardial effective transverse relaxation rate at 1.5, 3.0, and 7.0 T

Cognitive, cardiac, and physiological safety studies in ultra high field magnetic resonance imaging

Computation of electromagnetic fields for high-frequency magnetic resonance imaging applications

Ultra-High-Field Imaging of the Pediatric Brain and Spinal Cord